These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7752770)

  • 1. Renal dysfunction during antihypertensive treatment.
    Cheung B
    Lancet; 1995 May; 345(8961):1365-6. PubMed ID: 7752770
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
    Parving HH; Andersen AR; Smidt UM; Hommel E; Mathiesen ER; Svendsen PA
    Br Med J (Clin Res Ed); 1987 Jun; 294(6585):1443-7. PubMed ID: 3111583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive treatment and the kidney.
    de Leeuw PW
    Cardiovasc Drugs Ther; 2002 Dec; 16(6):483-4. PubMed ID: 12797365
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of 14 years of antihypertensive treatment on renal function and urinary albumin excretion in primary hypertension.
    Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
    Am J Hypertens; 1996 Sep; 9(9):841-9. PubMed ID: 8879339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.
    Wittenberg C; Rosenfeld JB
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):191S-193S. PubMed ID: 1827019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. At risk nephrons and the decline in renal function in response to treatment of hypertension.
    Walker WG; Ford C
    Trans Am Clin Climatol Assoc; 1996; 107():134-43; discussion 143-5. PubMed ID: 8725567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel-group 8-week study on chlorthalidone effects in hypertensives with low kidney function.
    Cirillo M; Marcarelli F; Mele AA; Romano M; Lombardi C; Bilancio G
    Hypertension; 2014 Apr; 63(4):692-7. PubMed ID: 24396024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic renal effects of guanfacine in essential and renal hypertension.
    Roeckel A; Heidland A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):141S-149S. PubMed ID: 6994769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function during antihypertensive treatment.
    Janssen WM; de Zeeuw D; de Jong PE
    Lancet; 1995 Jul; 346(8968):193. PubMed ID: 7661981
    [No Abstract]   [Full Text] [Related]  

  • 11. The natural course of glomerular filtration rate and arterial blood pressure in diabetic nephropathy, and the effect of antihypertensive treatment.
    Parving HH; Andersen AR; Smidt U; Friisberg B; Bonnevie-Nielsen V; Svendsen PA
    Acta Endocrinol Suppl (Copenh); 1981; 242():39-40. PubMed ID: 6940399
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal function during antihypertensive treatment.
    Kudo K
    Lancet; 1995 Jul; 346(8968):192-3. PubMed ID: 7603265
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calcium channel blocking agents and albuminuria in diabetic and hypertensive patients. A pilot study].
    Lamarre-Cliche M; Lambert R; Van Nguyen P; Cusson J; Wistaff R; Larochelle P
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):919-24. PubMed ID: 10989730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension.
    Alnima T; de Leeuw PW; Tan FE; Kroon AA;
    Hypertension; 2013 Jun; 61(6):1334-9. PubMed ID: 23589562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
    Viazzi F; Piscitelli P; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal dose of losartan for renoprotection in diabetic nephropathy.
    Andersen S; Rossing P; Juhl TR; Deinum J; Parving HH
    Nephrol Dial Transplant; 2002 Aug; 17(8):1413-8. PubMed ID: 12147788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of felodipine in hypertension.
    Leonetti G; Terzoli L; Rupoli L; Gradnik R; Zanchetti A
    Drugs; 1987; 34 Suppl 3():59-66. PubMed ID: 3443065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities of achieving target blood pressure in patients with essential hypertension in relation to renal functional status and age].
    Dmitrova TB; Kotovskaia IuV; Kobalava ZhD; Moiseev VS
    Ter Arkh; 2002; 74(12):29-33. PubMed ID: 12577836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.